Provided by Tiger Trade Technology Pte. Ltd.

Merck

152.55
+3.562.39%
Post-market: 153.160.6100+0.40%19:59 EDT
Volume:15.98M
Turnover:2.44B
Market Cap:376.37B
PE:119.85
High:154.49
Open:149.12
Low:148.59
Close:148.99
52wk High:154.49
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.07
T/O Rate:0.65%
Dividend:3.32
Dividend Rate:2.18%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.98
PE(LYR):20.95

Loading ...

Lupin Launches Generic Version of Merck's Bridion in US Market Following FDA Approval

Deep News
·
Jul 31

Merck Announces Q3 2026 Distribution of R$ 0.37 Per Unit, Payable Oct. 14

Reuters
·
Jul 31

Lupin to Sell Generic Version of Merck's Bridion in U.S. After FDA Approval

Dow Jones
·
Jul 31

Scribe's Genetic Editing Aims to Prevent Heart Attacks

Dow Jones
·
Jul 30

Merck, Wellcome Partner with Global Health Group to Make Ebola Vaccine for Clinical Trials

Reuters
·
Jul 30

Merck & Co. Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Merck Keeps Quarterly Dividend at $0.85 per Share; Payable Oct. 7 to Holders of Record on Sept. 15

MT Newswires Live
·
Jul 30

Merck & Co - Declares Q4 2026 Dividend of $0.85 Per Share

THOMSON REUTERS
·
Jul 29

Press Release: Merck Announces Fourth-Quarter 2026 Dividend

Dow Jones
·
Jul 29

MerckRapidly Advances ADC+IO 2.0 Strategy with SKB BIO's TROP2 ADC Joint PD-1/VEGF Bispecific Antibody Phase II Trial

Deep News
·
Jul 29

US Lawmakers Press Health Secretary Robert F. Kennedy Jr. on Vaccine Settlement

Reuters
·
Jul 29

Merck price target raised to $150 from $140 at Barclays

TIPRANKS
·
Jul 29

Earning Preview: Merck Q2 revenue expected to increase by 2.98%, and institutional views are mostly bullish

Earnings Agent
·
Jul 29

Xetra Closing Stock Prices

Dow Jones
·
Jul 29

Movement Alert|Merck Rises 3.12% in Regular Trading, Pharma Sector Rally and Barclays Target Price Upgrade

Market Focus
·
Jul 28

Merck & Co. on Track for Record High Close

Dow Jones
·
Jul 28

Barclays Adjusts Merck & Co. Price Target to $150 From $140, Maintains Overweight Rating

MT Newswires Live
·
Jul 28

Merck & Co Inc : Bernstein Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 27

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative

Simply Wall St.
·
Jul 26

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Simply Wall St.
·
Jul 25